The Effect of Efavirenz on Reward Processing in Asymptomatic People Living with HIV: A Randomized Controlled Trial

Keyphrases

• Randomized Controlled Trial 100%
• Reward Processing 100%
• People Living with HIV (PLHIV) 100%
• Efavirenz 100%
• Reward Anticipation 30%
• Reward Outcome 30%
• Monetary Incentive Delay Task 20%
• Motivational Control 20%
• Rilpivirine 20%
• Fast Response 10%
• Reward System 10%
• Ventral Striatum 10%
• Functional Magnetic Resonance Imaging 10%
• Education Level 10%
• Adult Participants 10%
• Asymptomatic Adults 10%
• Magnetic Resonance Imaging Study 10%
• HIV Infection 10%
• Frontostriatal Circuits 10%
• Learning Effect 10%
• Antiviral Drugs 10%
• Emtricitabine 10%
• Activation Level 10%
• Orbitofrontal Cortex 10%
• Depressive 10%
• Multicenter Randomized Controlled Trial 10%
• Fumarate 10%
• Behavioral Level 10%
• Apathy 10%
• HIV Diagnosis 10%
• Neurocognitive Effects 10%
• Response Accuracy 10%
• Functional Brain Activity 10%
• Outcome Processing 10%
• Switch Therapy 10%
• Blood Oxygenation Level-dependent MRI 10%
• Therapy Switch 10%
• Time Inconsistency 10%
• Different Characteristics 10%
• Potential for Learning 10%
• HIV Population 10%

Neuroscience

• Efavirenz 100%
• Randomized Controlled Trial 100%
• Human Immunodeficiency Virus 100%
• Functional Magnetic Resonance Imaging 20%
• Rilpivirine 20%
• Behavior (Neuroscience) 10%
• Reward System 10%
• Ventral Striatum 10%
• Orbitofrontal Cortex 10%
• Antiretroviral Drugs 10%
• Blood-Oxygen-Level Dependent 10%
• Electroencephalogram 10%
• Emtricitabine 10%

Psychology

• Functional Magnetic Resonance Imaging 100%
• Blood Oxygen Level 50%
• Orbitofrontal Cortex 50%
• Corpus Striatum 50%
• Electroencephalogram 50%